Impact BioMedical, INC. (IBO) Net Margin
- 2026-06-30: Net Margin -23300.00%.
- 2026-03-31: Net Margin -32671.43%.
- 2025-12-31: Net Margin 74928.57%.
- 2025-09-30: Net Margin -8166.67%.
Complete source-backed net margin history.
- Available history
- 2022-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -23300.00% |
| 2026-03-31 | -32671.43% |
| 2025-12-31 | 74928.57% |
| 2025-09-30 | -8166.67% |
| 2025-06-30 | -204942.86% |
| 2022-06-30 | -1598.00% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -36993.75% |
| 2022-12-31 | -14510.00% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |